Haohai Biological Technology buys back shares, establishes cash management account

Shanghai Haohai Biological Technology Company Limited submitted its monthly return of changes in issued share capital and share buybacks for November 2025. The company's registered share capital as of November 30, 2025, remains unchanged at RMB 38,529,240 for H-shares and RMB 194,051,855 for A-shares. The total issued H-shares also remained at 38,529,240, with 190,203,760 A-shares.

The company announced a series of H-share buybacks in November 2025, with 1,687,200 H-shares purchased in various transactions. As of December 2, 2025, an additional 102,100 H-shares were bought back on the Hong Kong Stock Exchange at prices between HK$27.26 and HK$27.54, totaling HK$2,798,864. The board approved buybacks of up to 3,914,184 shares, of which 1,864,200 have been repurchased.

Additionally, the company opened a dedicated settlement account for cash management products at Shanghai Pudong Development Bank's Changning Sub-branch. This follows the board's approval on November 7, 2025, to utilize up to RMB300,000,000 of temporarily idle raised funds for secure, liquid, and principal-guaranteed investment products.